Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: twentyfirstcenturyfox who wrote (11414)	11/20/2002 12:09:49 AM
From: padco	Read Replies (1) \| Respond to of 14101

Fox, its nice to see that you're becoming more appreciative of Jim's work. Sometimes we have to get him away from that other thread, where people stake out their beliefs behind mental fortresses protected by crocodile infested moats. You asked on Sunday whether the transdermal delivery system used in <fungoff> would be exactly the same as in Pennsaid. I'd answer that only the scientists at Dimethaid would know <exactly>. However, you can be assured that DMSO would be the solvent carrier of an anti-fungal agent with which it could be joined at the molecular level. PHew! There may be people on this thread that could tell us what anti-fungal Dimethaid is looking at. If you look at pages 8 and 9 of the Annual Report, there is a discussion of their progess in this field. Incidently, Dimethaid's idea to use DMSO as a carrier of an anti-fungal medication through the toe-nail is not new. Here's a link to my Google search on DMSO and toenail fungus. google.ca Sweet dreams and happy reading tonight!! <gg>